Enhanced immunosuppressive activity associated with metastatic lymphoma cells
- PMID: 8385575
Enhanced immunosuppressive activity associated with metastatic lymphoma cells
Abstract
Earlier reports from our laboratory showed that Abelson virus-induced, highly malignant and liver metastatic RAW117-H10 cells, but not the parental, less metastatic RAW117-P cells, inhibited both T-cell and B-cell mitogen-induced proliferation of syngeneic normal murine spleen cells. Similar inhibition was also noted when RAW117-H10 cell surface molecules extracted with butanol were used instead of whole tumor cells. In this report we describe the suppressive properties of the butanol-extracted RAW117-H10 cell surface molecules on other immune functions and the isolation/purification of a molecule from RAW117-H10 cell butanol extract which shows inhibitory activity. The immunosuppressive molecules also inhibit natural killer cell-mediated cytotoxicity, lymphokine-activated killer cell-mediated cytotoxicity, and bone marrow colony-forming unit-granulocyte-macrophage colony formation, but not colony-forming unit-fibroblast colony formation. The suppressive molecules inhibit interleukin 2 production by the T-lymphocytes. One of the molecules responsible for some of the immunosuppressive activity has been isolated and purified from butanol extracts of the metastatic RAW117-H10 cells by preparative isoelectrofocusing techniques. The suppressive molecule has an isoelectric point of 4.3 with an approximate molecular weight of 70,000. Metastatic RAW117-H10 lymphoma cells therefore express immunosuppressive molecules, which may facilitate their growth and metastasis in vivo.
Similar articles
-
Cell surface properties associated with malignancy of metastatic large cell lymphoma cells.Cancer Res. 1987 Jul 1;47(13):3551-7. Cancer Res. 1987. PMID: 3581088
-
Immunosuppression by metastatic lymphoma derived altered retroviral gp70 molecule.Leukemia. 1997 Apr;11 Suppl 3:202-5. Leukemia. 1997. PMID: 9209341
-
Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells.Cancer Detect Prev. 1988;11(3-6):405-17. Cancer Detect Prev. 1988. PMID: 3390859
-
Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma.J Cell Biochem. 1988 Apr;36(4):393-403. doi: 10.1002/jcb.240360408. J Cell Biochem. 1988. PMID: 3379107
-
Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells.Clin Exp Metastasis. 1991 Jan-Feb;9(1):27-37. doi: 10.1007/BF01831707. Clin Exp Metastasis. 1991. PMID: 2015714
Cited by
-
Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.J Cancer. 2010 Nov 29;1:230-41. doi: 10.7150/jca.1.230. J Cancer. 2010. PMID: 21151581 Free PMC article.
-
Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice.Clin Exp Metastasis. 1994 Jan;12(1):37-46. doi: 10.1007/BF01784332. Clin Exp Metastasis. 1994. PMID: 8287619
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical